Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Nebivolol (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 19 Feb 2016 According to ClinicalTrials.gov record, the primary endpoints have been amended.
- 19 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 17 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.